The analgesic properties of delta-9-tetrahydrocannabinol and codeine.

Category Primary study
JournalClinical pharmacology and therapeutics
Year 1975
Loading references information
The administration of single oral doses of delta-9-tetrahydrocannabinol (THC) to patients with cancer pain demonstrated a mild analgesic effect. At a dose of 20 mg, however, THC induced side effects that would prohibit its therapeutic use including somnolence, dizziness, ataxia, and blurred vision. Alarming adverse reactions were also observed at this dose. THC, 10 mg, was well tolerated and, despite its sedative effect, may analgesic potential.
Epistemonikos ID: 5a7f36caa5964952aa1d75485a372634b88acb0a
First added on: May 15, 2012